Can methotrexate reduce the renal toxicity of parenteral gold?
作者信息
Rau R, Wassenberg S, Herborn G
出版信息
J Rheumatol. 1993 Apr;20(4):759-61.
PMID:8496883
Abstract
摘要
相似文献
1
Can methotrexate reduce the renal toxicity of parenteral gold?甲氨蝶呤能降低胃肠外金制剂的肾毒性吗？
J Rheumatol. 1993 Apr;20(4):759-61.
2
Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.与甲氨蝶呤单药治疗相比，甲氨蝶呤（MTX）与肌肉注射金制剂或其他改善病情抗风湿药联合用于难治性和破坏性类风湿关节炎的长期治疗。
J Rheumatol. 1998 Aug;25(8):1485-92.
3
Localized lymphoma in a patient with rheumatoid arthritis treated with parenteral methotrexate.一名接受肠胃外甲氨蝶呤治疗的类风湿关节炎患者发生局限性淋巴瘤。
J Rheumatol. 1993 Dec;20(12):2172-3.
4
Renal effect of low dose methotrexate in rheumatoid arthritis.低剂量甲氨蝶呤对类风湿关节炎的肾脏影响。
J Rheumatol. 1994 Jun;21(6):1168.
5
Safety of combination therapy with hydroxychloroquine, gold sodium thiomalate and methotrexate in early rheumatoid arthritis.羟氯喹、硫代苹果酸金钠与甲氨蝶呤联合治疗早期类风湿性关节炎的安全性
Rev Rhum Engl Ed. 1997 Jul-Sep;64(7-9):521-2.
6
[Use of chrysotherapy in the treatment of rheumatoid arthritis].[金疗法在类风湿关节炎治疗中的应用]
Ter Arkh. 1981;53(7):78-80.
7
Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis.与用于治疗类风湿关节炎的改善病情抗风湿药相关的肾毒性。
Semin Arthritis Rheum. 2000 Dec;30(3):196-208. doi: 10.1053/sarh.2000.16641.
8
[Ocular affections in parenteral gold treatment of chronic polyarthritis].[慢性多关节炎肠胃外金治疗中的眼部病变]
Z Rheumaforsch. 1969 Nov-Dec;28(11):441-7.
9
A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.甲氨蝶呤与肌肉注射金制剂联合治疗类风湿关节炎的48周随机双盲双观测者安慰剂对照多中心试验：METGO研究结果
Arthritis Rheum. 2005 May;52(5):1360-70. doi: 10.1002/art.21018.
10
The cost of parenteral gold vs oral gold in the longterm treatment of rheumatoid arthritis.肠胃外金制剂与口服金制剂在类风湿关节炎长期治疗中的成本比较
J Rheumatol. 1986 Jun;13(3):663-4.
引用本文的文献
1
Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.低剂量脉冲甲氨蝶呤在类风湿关节炎中的临床药代动力学
Clin Pharmacokinet. 1996 Mar;30(3):194-210. doi: 10.2165/00003088-199630030-00002.
2
Methotrexate in rheumatoid arthritis. An update.类风湿关节炎中的甲氨蝶呤。最新进展。
Drugs. 1994 Jan;47(1):25-50. doi: 10.2165/00003495-199447010-00003.
Zotero 插件